165 related articles for article (PubMed ID: 36725842)
1. LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1-TINCR-USP20-PD-L1 axis.
Wang Q; Li G; Ma X; Liu L; Liu J; Yin Y; Li H; Chen Y; Zhang X; Zhang L; Sun L; Ai J; Xu S
Cell Death Dis; 2023 Feb; 14(2):76. PubMed ID: 36725842
[TBL] [Abstract][Full Text] [Related]
2. LncRNA TINCR favors tumorigenesis via STAT3-TINCR-EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer.
Wang Q; Liu J; You Z; Yin Y; Liu L; Kang Y; Li S; Ning S; Li H; Gong Y; Xu S; Pang D
Cell Death Dis; 2021 Jan; 12(1):83. PubMed ID: 33446634
[TBL] [Abstract][Full Text] [Related]
3. Let-7a/cMyc/CCAT1/miR-17-5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1.
Selem NA; Nafae H; Manie T; Youness RA; Gad MZ
Pathol Res Pract; 2023 Aug; 248():154579. PubMed ID: 37301086
[TBL] [Abstract][Full Text] [Related]
4. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
5. The miR-199a-5p/PD-L1 axis regulates cell proliferation, migration and invasion in follicular thyroid carcinoma.
Lin J; Qiu Y; Zheng X; Dai Y; Xu T
BMC Cancer; 2022 Jul; 22(1):756. PubMed ID: 35818041
[TBL] [Abstract][Full Text] [Related]
6. lncRNA MIAT targets miR-411-5p/STAT3/PD-L1 axis mediating hepatocellular carcinoma immune response.
Zhang X; Pan B; Qiu J; Ke X; Shen S; Wang X; Tang N
Int J Exp Pathol; 2022 Jun; 103(3):102-111. PubMed ID: 35429078
[TBL] [Abstract][Full Text] [Related]
7. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
Zhang M; Xu Y; Yin S; Qiu F
Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.
Zhao H; Xie Z; Tang G; Wei S; Chen G
J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189
[TBL] [Abstract][Full Text] [Related]
9. LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p/SOX4 axis and activating IFNγ-JAK2-STAT1 pathway.
Du L; Wang B; Wu M; Chen W; Wang W; Diao W; Ding M; Chen W; Cao W; Guo H; Zhang G
Cancer Lett; 2023 Dec; 578():216463. PubMed ID: 37866544
[TBL] [Abstract][Full Text] [Related]
10. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast Cancer.
Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M
Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694
[TBL] [Abstract][Full Text] [Related]
11. Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis.
Li C; Pan B; Wang X; Liu X; Qin J; Gao T; Sun H; Pan Y; Wang S
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1965-1982. PubMed ID: 35357586
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression.
Peng L; Pan B; Zhang X; Wang Z; Qiu J; Wang X; Tang N
Cell Biol Toxicol; 2022 Dec; 38(6):1159-1173. PubMed ID: 35438468
[TBL] [Abstract][Full Text] [Related]
13. [Plasma exosomal miR-335-5p serves as a diagnostic indicator and inhibits immune escape in triple-negative breast cancer].
Chen T; Dong Y; Wu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Apr; 38(4):347-356. PubMed ID: 35583065
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p.
Zhou WY; Zhang MM; Liu C; Kang Y; Wang JO; Yang XH
J Cell Physiol; 2019 Dec; 234(12):23176-23189. PubMed ID: 31206665
[TBL] [Abstract][Full Text] [Related]
15. Oleuropin controls miR-194/XIST/PD-L1 loop in triple negative breast cancer: New role of nutri-epigenetics in immune-oncology.
Hamed MM; Handoussa H; Hussein NH; Eissa RA; Abdel-Aal LK; El Tayebi HM
Life Sci; 2021 Jul; 277():119353. PubMed ID: 33798547
[TBL] [Abstract][Full Text] [Related]
16. microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1.
Jiang K; Zou H
Bioengineered; 2022 Jan; 13(1):917-929. PubMed ID: 34968160
[TBL] [Abstract][Full Text] [Related]
17. LncRNA
Xu YJ; Zhao JM; Ni XF; Wang W; Hu WW; Wu CP
Epigenomics; 2021 Aug; 13(16):1281-1297. PubMed ID: 34523356
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer.
Liu Y; Du Y; Hu X; Zhao L; Xia W
BMC Cancer; 2018 Apr; 18(1):367. PubMed ID: 29614984
[TBL] [Abstract][Full Text] [Related]
19. Yin Yang 1-stimulated long noncoding RNA bladder cancer-associated transcript 1 upregulation facilitates esophageal carcinoma progression via the microRNA-5590-3p/programmed cell death-ligand 1 pathway.
Cheng J; Yang Q; Han X; Wang H; Wu K; Zhao H
Bioengineered; 2022 Apr; 13(4):10244-10257. PubMed ID: 35435118
[TBL] [Abstract][Full Text] [Related]
20. SP1-induced lncRNA TINCR overexpression contributes to colorectal cancer progression by sponging miR-7-5p.
Yu S; Wang D; Shao Y; Zhang T; Xie H; Jiang X; Deng Q; Jiao Y; Yang J; Cai C; Sun L
Aging (Albany NY); 2019 Mar; 11(5):1389-1403. PubMed ID: 30853664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
